News response Seems to be a tepid response to the write-up with a paltry 40 shares traded so far.
This is a "show me the money" stock now and until they do that it likely isn't going to see a tremendous amount of action.
If they could announce some AbbVie milestones or royalties on the near horizon that would be an ideal catalyst to jolt this back to life.